Chung Eunice, Ewald Louisa, Kassembaum Nicholas J, Noyes Taylor, Gakidou Emmanuela, Mokdad Ali H
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States.
Department of Health Metrics, University of Washington, Seattle, WA, United States.
Int J Public Health. 2025 Jan 6;69:1607667. doi: 10.3389/ijph.2024.1607667. eCollection 2024.
This study analyzes survey data across 21 countries to explore correlations between delays in blood testing and the prevalence of seven health conditions: thalassaemias, sickle cell disorders, malaria, HIV, high fasting plasma glucose, impaired kidney function, and high LDL cholesterol.
We analyzed Pandemic Recovery Survey data via multivariable logistic regression to compare blood test delays between individuals with and without medical conditions, while adjusting for sociodemographic factors. We also examined the disease burden using disability-adjusted life years (DALYs) and summary exposure values (SEV) rates.
Our findings indicate profound disparities, with over 60% of respondents in Egypt, Nigeria, and India reporting they have never undergone blood tests. Individuals with existing medical conditions are significantly more likely to experience delays in blood work.
There is a pronounced gap in blood work accessibility, particularly in countries with high disease burdens. Findings suggest an urgent need for interventions to improve routine blood test access for high-risk populations to reduce the underdiagnosis of significant medical conditions. Prioritizing timely and accessible blood testing can serve as a step towards mitigating healthcare disparities.
本研究分析了21个国家的调查数据，以探讨血液检测延迟与七种健康状况的患病率之间的相关性，这七种健康状况分别为：地中海贫血、镰状细胞病、疟疾、艾滋病毒、空腹血糖高、肾功能受损和低密度脂蛋白胆固醇高。
我们通过多变量逻辑回归分析了大流行恢复调查数据，以比较有和没有健康问题的个体之间的血液检测延迟情况，同时对社会人口学因素进行了调整。我们还使用伤残调整生命年（DALYs）和汇总暴露值（SEV）率来检查疾病负担。
我们的研究结果表明存在巨大差异，埃及、尼日利亚和印度超过60%的受访者表示他们从未进行过血液检测。患有现有健康问题的个体进行血液检测时显著更有可能出现延迟。
在血液检测可及性方面存在明显差距，尤其是在疾病负担高的国家。研究结果表明迫切需要采取干预措施，以改善高危人群获得常规血液检测的机会，减少重大健康问题的漏诊。优先考虑及时且可及的血液检测可作为缓解医疗保健差距的一步。
